Wanbury Stock Screener | Share Price & Fundamental Analysis
WANBURY
Pharmaceuticals
Screen Wanbury share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹226.58
▼
-9.43 (-4.00%)
Share Price BSE
₹227.05
▼
-8.35 (-3.55%)
Market Cap
₹761.43 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
10.53
EPS (TTM)
₹9.32
Dividend Yield
-
Debt to Equity
3.38
52W High
₹312.65
52W Low
₹160.29
Operating Margin
17.00%
Profit Margin
11.49%
Revenue (TTM)
₹174.00
EBITDA
₹32.00
Net Income
₹20.00
Total Assets
₹414.00
Total Equity
₹59.00
Wanbury Share Price History - Stock Screener Chart
Screen WANBURY historical share price movements with interactive charts. Analyze price trends and patterns.
Wanbury Company Profile - Fundamental Screener
Screen Wanbury company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for WANBURY shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE107F01022
Wanbury Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen WANBURY balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 414 | 343 | 304 | 353 | 289 | 279 | 286 | 273 | 412 | 388 |
| Current Assets | 193 | 159 | 122 | 171 | 98 | 90 | 94 | 74 | 192 | 164 |
| Fixed Assets | 201 | 167 | 167 | 167 | 167 | 164 | 172 | 178 | 186 | 180 |
| Liabilities | ||||||||||
| Total Liabilities | 414 | 343 | 304 | 353 | 289 | 279 | 286 | 273 | 412 | 388 |
| Current Liabilities | 180 | 105 | 16 | 16 | 90 | 111 | 134 | 109 | 163 | 251 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 59 | 28 | -33 | -23 | -156 | -144 | -209 | -185 | -153 | -162 |
| Share Capital | 33 | 33 | 33 | 33 | 25 | 25 | 24 | 24 | 23 | 20 |
| Reserves & Surplus | 21 | -11 | -66 | -56 | -181 | -168 | -233 | -208 | -177 | -221 |
Screen WANBURY income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec | 2021-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 174 | 164 | 166 | 132 | 163 | 134 | 131 | 147 | 145 | 146 | 211 | 119 | 125 | 126 | 122 |
| Expenses | 142 | 139 | 121 | 120 | 141 | 120 | 119 | 133 | 127 | 124 | 122 | 120 | 118 | 119 | 122 |
| EBITDA | 32 | 25 | 45 | 12 | 22 | 15 | 12 | 14 | 18 | 22 | 90 | -1 | 6 | 7 | -1 |
| Operating Profit % | 17.00% | 15.00% | 13.00% | 8.00% | 12.00% | 10.00% | 10.00% | 9.00% | 12.00% | 15.00% | 10.00% | -3.00% | 5.00% | 5.00% | -1.00% |
| Depreciation | 3 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Interest | 9 | 8 | 8 | 8 | 10 | 10 | 8 | 6 | 8 | 8 | 5 | 3 | 4 | 7 | 6 |
| Profit Before Tax | 19 | 14 | 34 | 1 | 8 | 1 | 1 | 5 | 7 | 10 | 82 | -7 | -1 | -3 | -9 |
| Tax | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 |
| Net Profit | 20 | 14 | 34 | 1 | 8 | 1 | 1 | 5 | 7 | 10 | 83 | -7 | -1 | -3 | -9 |
| EPS | 6.18 | 4.12 | 10.28 | 0.32 | 2.44 | 0.38 | 0.31 | 1.43 | 2.25 | 3.14 | 25.62 | -2.22 | -0.27 | -1.00 | -3.58 |
Wanbury Cash Flow Screener - Liquidity Fundamentals
Screen WANBURY cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 26 | 5 | 20 | 41 | 17 | 44 | 30 | 33 | 43 | 43 |
| Investing Activities | -51 | -17 | -9 | 1 | 8 | 64 | -3 | -1 | -13 | -20 |
| Financing Activities | 26 | 14 | -32 | -29 | -17 | -108 | -27 | -33 | -27 | -28 |
| Net Cash Flow | 1 | 2 | -21 | 13 | 7 | 0 | 0 | -2 | 3 | -5 |
Screen WANBURY shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 39.76% | 39.63% | 43.09% | 39.79% | 39.79% | 39.77% | 39.76% | 39.84% |
| FII Holding | 1.55% | 1.59% | 0.82% | 0.18% | 0.22% | 1.02% | 0.84% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.13% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 41.78% | 42.06% | 41.19% | 41.81% | 41.42% | 40.66% | 39.61% | 37.83% |
| Other Holding | 16.90% | 16.71% | 14.89% | 18.22% | 18.57% | 18.54% | 19.79% | 22.20% |
| Shareholder Count | 17,889 | 17,894 | 17,717 | 13,087 | 14,400 | 17,199 | 17,999 | 11,911 |
Wanbury Dividend Screener - Share Yield Analysis
Screen WANBURY dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Wanbury Index Membership - Market Screener Classification
Screen WANBURY by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Wanbury Market Events Screener - Corporate Actions
Screen WANBURY market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -12.35% | ||
| Annual General Meeting | NA | 27.65% | ||
| Annual General Meeting | NA | 15.79% | ||
| 2026-01-05 | 2026-01-05 | Extraordinary General Meeting | NA | 0.19% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -8.84% |
| 2025-08-04 | 2025-08-04 | Quarterly Result Announcement | NA | 9.64% |
| 2025-05-15 | 2025-05-15 | Quarterly Result Announcement | NA | 11.57% |
| 2025-02-20 | 2025-02-20 | Extraordinary General Meeting | NA | -25.55% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -11.84% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | 10.56% |
| 2023-08-21 | 2023-08-21 | Extraordinary General Meeting | NA | 3.28% |
Wanbury Competitors Screener - Peer Comparison
Screen WANBURY competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 412,734 | 39.30 | 54,729 | 9.71% | 10,980 | 39.06 |
| Divis Laboratories | 168,851 | 68.25 | 9,712 | 18.67% | 2,191 | 44.96 |
| Torrent Pharmaceuticals | 129,357 | 59.98 | 11,539 | 6.99% | 1,911 | 59.35 |
| Cipla | 120,557 | 22.21 | 28,410 | 7.12% | 5,291 | 42.76 |
| Dr Reddys Laboratories | 105,645 | 18.46 | 33,741 | 16.73% | 5,725 | 49.97 |
| Lupin | 95,023 | 21.85 | 22,910 | 13.74% | 3,306 | 50.10 |
| Zydus Life Science | 90,707 | 18.09 | 23,511 | 18.55% | 4,615 | 34.06 |
| Mankind Pharma | 88,846 | 50.78 | 12,744 | 20.90% | 2,007 | 40.67 |
| Aurobindo Pharma | 68,901 | 20.36 | 32,346 | 9.43% | 3,484 | 46.33 |
| Alkem Laboratories | 65,390 | 27.28 | 13,458 | 3.70% | 2,216 | 37.45 |
Wanbury Company Announcements - News Screener
Screen WANBURY latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-06 | Closure of Trading Window | View |
| 2025-12-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-12-12 | Notice Of Book Closure For The Purpose Of Extra-Ordinary General Meeting (EOGM) To Be Held On 5Th January 2026 Through Video Conferencing (VC) / Other Audio Visual Means (OAVM). | View |
| 2025-12-12 | Notice Of The Extra Ordinary General Meeting Of Wanbury Limited To Be Held On 5Th January 2026 Through Video Conferencing (VC) / Other Audio Visual Means (OAVM). | View |
| 2025-12-11 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-12-10 | Board Meeting Outcome for Outcome Of The Board Meeting Held On 10Th December 2025 In Accordance With Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 ("SEBI Listing Regulations" | View |
| 2025-12-01 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-11-24 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-22 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-18 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Allotment | View |
| 2025-11-13 | Outcome Of The Board Meeting Held On November 13 2025 | View |
| 2025-11-13 | Board Meeting Outcome for Outcome Of The Board Meeting Held On November 13 2025 | View |
| 2025-11-06 | Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 | View |
| 2025-10-15 | Announcement under Regulation 30 (LODR)-Allotment | View |
| 2025-10-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-06 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-09-29 | Closure of Trading Window | View |
| 2025-09-19 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-18 | Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association | View |